| Catalog Number |
D160901 |
| Medical Device Problem Codes |
Contamination /Decontamination Problem (2895); Manufacturing, Packaging or Shipping Problem (2975)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/06/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a octaray mapping catheter and a "hair-like" material on one of the splines.It was reported that after opening the product packaging and placing the octaray mapping catheter in the sterile field, it was noticed that there was a two or three inch long "hair-like" material; with movement, on one of the splines of the octaray mapping catheter.The octaray mapping catheter was replaced and the procedure continued.There was no patient consequence.The device was not used on the patient.
|
| |
|
Additional Manufacturer Narrative
|
|
On (b)(6) 2026, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with an octaray mapping catheter and a "hair-like" material on one of the splines.Device evaluation details: the device was returned to johnson & johnson medtech (j&j) for evaluation.A visual inspection evaluation of the returned device was performed following j&j medtech procedures.Visual inspection of the returned sample revealed no damage or anomalies on the device.No foreign material was observed in any section of the catheter.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The foreign material issue reported by the customer could not be confirmed during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.The catheter instructions for use (ifu) contain the following recommendations: inspect the sterile packaging and catheter prior to use.As part of the johnson & johnson medtech quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
| |
|
Search Alerts/Recalls
|